2006
DOI: 10.1177/1721727x0600400304
|View full text |Cite
|
Sign up to set email alerts
|

HSP70 Modulates the Enhanced Production of Reactive Intermediate Metabolites and a Proinflammatory Cytokine TNF-α Expression in a T Cell Lymphoma

Abstract: Heat shock proteins are intracellular soluble proteins expressed consecutively in all cells. They are immunogenic proteins able to activate antigen-presenting cells by binding through the CD91 receptor and activate both CD4+ and CD8+ T-cells. Macrophage plays a pivotal role in innate immune response and secretes a number of regulatory molecules upon activation. In the present study, we investigate the activation of normal and tumor-associated macrophage to produce the effector molecules which have a role in im… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 30 publications
(28 reference statements)
0
1
0
Order By: Relevance
“…However, in the previous studies of HSP70, the dose was generally HSP70 266 ug/KgBB/ip to suggest, exogenous HSP70 dose of 266 μg/kgBW in mice increases the number of BCL 2 which can inhibit apoptosis [18]. In his study, Kumar et al used HSP70 injection tumor models, dosages varied from 1 µg to 100 µg to improve TNF-α production [24]. As Choudhoury et al (2011) states, exogenous HSP70 administration inhibits apoptosis through the prevention of Cyt c complex release pathways, apoptotic proteaseactivating factor 1 (apaf 1), pro-Caspase 9 and 3.…”
Section: Discussionmentioning
confidence: 99%
“…However, in the previous studies of HSP70, the dose was generally HSP70 266 ug/KgBB/ip to suggest, exogenous HSP70 dose of 266 μg/kgBW in mice increases the number of BCL 2 which can inhibit apoptosis [18]. In his study, Kumar et al used HSP70 injection tumor models, dosages varied from 1 µg to 100 µg to improve TNF-α production [24]. As Choudhoury et al (2011) states, exogenous HSP70 administration inhibits apoptosis through the prevention of Cyt c complex release pathways, apoptotic proteaseactivating factor 1 (apaf 1), pro-Caspase 9 and 3.…”
Section: Discussionmentioning
confidence: 99%